Showing 8 of 8 recruiting trials for “oligoastrocytic-tumor”
Tuvusertib in Astrocytoma With ATRX Mutation
👨⚕️ Estela Pineda, M.D.; Ph.D., Medical Oncology, Hospital Clínic de Barcelona📍 10 sites📅 Started Dec 2025View details ↗
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
👨⚕️ Elaine T Kiriakopoulos, MD, MPH, MSc, Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College📍 1 site📅 Started Nov 2025View details ↗
Study of How Safe and Effective Tarlatamab is in Brain Cancers
👨⚕️ Eric Chen, MD, Princess Margaret Cancer Centre/University Health Network📍 1 site📅 Started Aug 2025View details ↗
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
👨⚕️ Erin K Barr, Pediatric Early Phase Clinical Trial Network📍 17 sites📅 Started Jun 2025View details ↗
RecruitingNCT06915649 ↗
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
👨⚕️ Howard Colman, MD, PhD, Huntsman Cancer Institute/ University of Utah📍 8 sites📅 Started Jul 2023View details ↗
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
RecruitingNCT04648462 ↗
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →